PTPI
Petros Pharmaceuticals, Inc.
Drug Manufacturers - Specialty & Generic
Market Cap$56K
5Y Perf.-100.0%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
PTPI vs PRGO
Revenue, margins, valuation, and 5-year total return — side by side.
PRGO
Perrigo Company plc
Drug Manufacturers - Specialty & Generic
Market Cap$1.62B
5Y Perf.-73.8%
PTPI vs PRGO — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | PTPI | PRGO |
|---|---|---|
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
| Market Cap | $56K | $1.62B |
| Revenue (TTM) | $725K | $4.18B |
| Net Income (TTM) | $-7M | $-1.82B |
| Gross Margin | 63.5% | 34.2% |
| Operating Margin | -18.4% | -4.1% |
| Forward P/E | — | 5.5x |
| Total Debt | $7M | $3.97B |
| Cash & Equiv. | $4M | $532M |
PTPI vs PRGO — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
PTPI
PRGO
| Stock | Dec 20 | May 26 | Return |
|---|---|---|---|
| Petros Pharmaceutic… (PTPI) | 100 | 0.0 | -100.0% |
| Perrigo Company plc (PRGO) | 100 | 26.2 | -73.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PTPI vs PRGO
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: PRGO leads in 5 of 6 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Petros Pharmaceuticals, Inc. is the stronger pick specifically for dividend income and shareholder returns. As sector peers, any of these can serve as alternatives in the same allocation.
PTPI
Petros Pharmaceuticals, Inc.
The Income Pick
PTPI is the clearest fit if your priority is dividends.
- 100.0% yield, 1-year raise streak, vs PRGO's 9.8%
Best for: dividends
PRGO
Perrigo Company plc
The Income Pick
PRGO carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 10 yrs, beta 1.21, yield 9.8%
- Rev growth -2.8%, EPS growth -7.2%, 3Y rev CAGR -1.5%
- -77.7% 10Y total return vs PTPI's -100.0%
Best for: income & stability and growth exposure
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | PRGO | -2.8% revenue growth vs PTPI's -12.2% |
| Quality / Margins | PRGO | -43.5% margin vs PTPI's -9.7% |
| Stability / Safety | PRGO | Beta 1.21 vs PTPI's 1.45 |
| Dividends | PTPI | 100.0% yield, 1-year raise streak, vs PRGO's 9.8% |
| Momentum (1Y) | PRGO | -52.0% vs PTPI's -94.4% |
| Efficiency (ROA) | PRGO | -19.8% ROA vs PTPI's -114.5%, ROIC 3.7% vs -7.3% |
PTPI vs PRGO — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2024
FY 2025
PTPI vs PRGO — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLPRGOLAGGINGPTPI
PTPIPetros Pharmaceutical…
0leads
PRGOPerrigo Company plc
4leads
6 Total Categories
CATEGORYLEADERvs PTPIMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
PRGO4/6
Valuation MetricsMultiples, price ratios, and targets
Tied
—
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
PRGO6/8
Total Returns1Y, 3Y, 5Y total returns with dividends
PRGO5/6
Risk & VolatilityBeta, volatility, and downside exposure
PRGO2/2
Analyst OutlookRatings, price targets, and dividends
Tied
—
Income & Cash Flow (Last 12 Months)
PRGO leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
PRGO is the larger business by revenue, generating $4.2B annually — 5760.1x PTPI's $725,403. Profitability is closely matched — net margins range from -43.5% (PRGO) to -9.7% (PTPI). On growth, PRGO holds the edge at -7.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | PTPIPetros Pharmaceut… | PRGOPerrigo Company p… |
|---|---|---|
| RevenueTrailing 12 months | $725,403 | $4.2B |
| EBITDAEarnings before interest/tax | -$12M | $58M |
| Net IncomeAfter-tax profit | -$7M | -$1.8B |
| Free Cash FlowCash after capex | -$5M | $108M |
| Gross MarginGross profit ÷ Revenue | +63.5% | +34.2% |
| Operating MarginEBIT ÷ Revenue | -18.4% | -4.1% |
| Net MarginNet income ÷ Revenue | -9.7% | -43.5% |
| FCF MarginFCF ÷ Revenue | -6.7% | +2.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | -100.0% | -7.2% |
| EPS Growth (YoY)Latest quarter vs prior year | +95.9% | -56.4% |
PRGO leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
Evenly matched — PTPI and PRGO each lead in 1 of 2 comparable metrics.
Valuation Metrics
| Metric | PTPIPetros Pharmaceut… | PRGOPerrigo Company p… |
|---|---|---|
| Market CapShares × price | $56,182 | $1.6B |
| Enterprise ValueMkt cap + debt − cash | $4M | $5.1B |
| Trailing P/EPrice ÷ TTM EPS | -0.00x | -1.14x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 5.53x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 7.43x |
| Price / SalesMarket cap ÷ Revenue | 0.01x | 0.38x |
| Price / BookPrice ÷ Book value/share | — | 0.55x |
| Price / FCFMarket cap ÷ FCF | — | 11.17x |
Evenly matched — PTPI and PRGO each lead in 1 of 2 comparable metrics.
Profitability & Efficiency
PRGO leads this category, winning 6 of 8 comparable metrics.
Profitability & Efficiency
PRGO delivers a -50.7% return on equity — every $100 of shareholder capital generates $-51 in annual profit, vs $-2 for PTPI. On the Piotroski fundamental quality scale (0–9), PRGO scores 4/9 vs PTPI's 3/9, reflecting mixed financial health.
| Metric | PTPIPetros Pharmaceut… | PRGOPerrigo Company p… |
|---|---|---|
| ROE (TTM)Return on equity | -2.1% | -50.7% |
| ROA (TTM)Return on assets | -114.5% | -19.8% |
| ROICReturn on invested capital | -7.3% | +3.7% |
| ROCEReturn on capital employed | -2.3% | +4.3% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 4 |
| Debt / EquityFinancial leverage | — | 1.35x |
| Net DebtTotal debt minus cash | $4M | $3.4B |
| Cash & Equiv.Liquid assets | $4M | $532M |
| Total DebtShort + long-term debt | $7M | $4.0B |
| Interest CoverageEBIT ÷ Interest expense | -79.35x | -7.20x |
PRGO leads this category, winning 6 of 8 comparable metrics.
Total Returns (Dividends Reinvested)
PRGO leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PRGO five years ago would be worth $3,969 today (with dividends reinvested), compared to $0 for PTPI. Over the past 12 months, PRGO leads with a -52.0% total return vs PTPI's -94.4%. The 3-year compound annual growth rate (CAGR) favors PRGO at -25.2% vs PTPI's -95.9% — a key indicator of consistent wealth creation.
| Metric | PTPIPetros Pharmaceut… | PRGOPerrigo Company p… |
|---|---|---|
| YTD ReturnYear-to-date | -12.5% | -13.6% |
| 1-Year ReturnPast 12 months | -94.4% | -52.0% |
| 3-Year ReturnCumulative with dividends | -100.0% | -58.1% |
| 5-Year ReturnCumulative with dividends | -100.0% | -60.3% |
| 10-Year ReturnCumulative with dividends | -100.0% | -77.7% |
| CAGR (3Y)Annualised 3-year return | -95.9% | -25.2% |
PRGO leads this category, winning 5 of 6 comparable metrics.
Risk & Volatility
PRGO leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
PRGO is the less volatile stock with a 1.21 beta — it tends to amplify market swings less than PTPI's 1.45 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PRGO currently trades 41.2% from its 52-week high vs PTPI's 3.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | PTPIPetros Pharmaceut… | PRGOPerrigo Company p… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.45x | 1.21x |
| 52-Week HighHighest price in past year | $0.21 | $28.44 |
| 52-Week LowLowest price in past year | $0.00 | $9.23 |
| % of 52W HighCurrent price vs 52-week peak | +3.3% | +41.2% |
| RSI (14)Momentum oscillator 0–100 | 47.2 | 53.1 |
| Avg Volume (50D)Average daily shares traded | 40K | 3.3M |
PRGO leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Evenly matched — PTPI and PRGO each lead in 1 of 2 comparable metrics.
Analyst Outlook
For income investors, PTPI offers the higher dividend yield at 100.00% vs PRGO's 9.82%.
| Metric | PTPIPetros Pharmaceut… | PRGOPerrigo Company p… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold |
| Price TargetConsensus 12-month target | — | $36.20 |
| # AnalystsCovering analysts | — | 36 |
| Dividend YieldAnnual dividend ÷ price | +100.0% | +9.8% |
| Dividend StreakConsecutive years of raises | 1 | 10 |
| Dividend / ShareAnnual DPS | $161.09 | $1.15 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
Evenly matched — PTPI and PRGO each lead in 1 of 2 comparable metrics.
Key Takeaway
PRGO leads in 4 of 6 categories — strongest in Income & Cash Flow and Profitability & Efficiency. 2 categories are tied.
Best OverallPerrigo Company plc (PRGO)Leads 4 of 6 categories
Loading custom metrics...
PTPI vs PRGO: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is PTPI or PRGO a better buy right now?
For growth investors, Perrigo Company plc (PRGO) is the stronger pick with -2.
8% revenue growth year-over-year, versus -12. 2% for Petros Pharmaceuticals, Inc. (PTPI). Analysts rate Perrigo Company plc (PRGO) a "Hold" — based on 36 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — PTPI or PRGO?
Over the past 5 years, Perrigo Company plc (PRGO) delivered a total return of -60.
3%, compared to -100. 0% for Petros Pharmaceuticals, Inc. (PTPI). Over 10 years, the gap is even starker: PRGO returned -77. 7% versus PTPI's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — PTPI or PRGO?
By beta (market sensitivity over 5 years), Perrigo Company plc (PRGO) is the lower-risk stock at 1.
21β versus Petros Pharmaceuticals, Inc. 's 1. 45β — meaning PTPI is approximately 19% more volatile than PRGO relative to the S&P 500.
04Which is growing faster — PTPI or PRGO?
By revenue growth (latest reported year), Perrigo Company plc (PRGO) is pulling ahead at -2.
8% versus -12. 2% for Petros Pharmaceuticals, Inc. (PTPI). On earnings-per-share growth, the picture is similar: Petros Pharmaceuticals, Inc. grew EPS 47. 4% year-over-year, compared to -723. 2% for Perrigo Company plc. Over a 3-year CAGR, PRGO leads at -1. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — PTPI or PRGO?
Perrigo Company plc (PRGO) is the more profitable company, earning -33.
5% net margin versus -280. 1% for Petros Pharmaceuticals, Inc. — meaning it keeps -33. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PRGO leads at 8. 1% versus -345. 8% for PTPI. At the gross margin level — before operating expenses — PTPI leads at 76. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — PTPI or PRGO?
All stocks in this comparison pay dividends.
Petros Pharmaceuticals, Inc. (PTPI) offers the highest yield at 100. 0%, versus 9. 8% for Perrigo Company plc (PRGO).
07Is PTPI or PRGO better for a retirement portfolio?
For long-horizon retirement investors, Perrigo Company plc (PRGO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.
21), 9. 8% yield). Both have compounded well over 10 years (PRGO: -77. 7%, PTPI: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between PTPI and PRGO?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(PTPI: -100.0% · PRGO: -7.2%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.